Volume 61; Issue 3

Cancer Immunology, Immunotherapy

Volume 61; Issue 3

1

SCF and TLR4 ligand cooperate to augment the tumor-promoting potential of mast cells

Jing-Jing Wei, Chuan-Wang Song, Ling-Cong Sun, Ye Yuan, Dong Li, Bin Yan, Sheng-Jun Liao, Jian-Hua Zhu, Qi Wang, Gui-Mei Zhang, Zuo-Hua Feng

Journal:

Cancer Immunology, Immunotherapy

Year:

2012

Language:

english

File:

PDF, 537 KB

english, 2012

2

Wilms' tumor protein 1 (WT1) peptide vaccination in AML patients: predominant TCR CDR3β sequence associated with remission in one patient is detectable in other vaccinated patients

Sebastian Ochsenreither, Alberto Fusi, Anne Geikowski, David Stather, Antonia Busse, Andrea Stroux, Anne Letsch, Ulrich Keilholz

Journal:

Cancer Immunology, Immunotherapy

Year:

2012

Language:

english

File:

PDF, 490 KB

english, 2012

3

A gynecologic oncology group phase II trial of two p53 peptide vaccine approaches: subcutaneous injection and intravenous pulsed dendritic cells in high recurrence risk ovarian cancer patients

Osama E. Rahma, Ed Ashtar, Malgorzata Czystowska, Marta E. Szajnik, Eva Wieckowski, Sarah Bernstein, Vincent E. Herrin, Mortada A. Shams, Seth M. Steinberg, Maria Merino, William Gooding, Carmen Visus

Journal:

Cancer Immunology, Immunotherapy

Year:

2012

Language:

english

File:

PDF, 529 KB

english, 2012

4

Role of CD44 in lymphokine-activated killer cell-mediated killing of melanoma

Jingping Sun, Gabriela P. Law, Robert J. McKallip

Journal:

Cancer Immunology, Immunotherapy

Year:

2012

Language:

english

File:

PDF, 578 KB

english, 2012

5

Metronomic cyclophosphamide treatment in metastasized breast cancer patients: immunological effects and clinical outcome

Yingzi Ge, Christoph Domschke, Natalija Stoiber, Sarah Schott, Joerg Heil, Joachim Rom, Maria Blumenstein, Janina Thum, Christof Sohn, Andreas Schneeweiss, Philipp Beckhove, Florian Schuetz

Journal:

Cancer Immunology, Immunotherapy

Year:

2012

Language:

english

File:

PDF, 488 KB

english, 2012

6

In vivo electroporation restores the low effectiveness of DNA vaccination against HER-2/neu in aging

Mauro Provinciali, Alessandra Barucca, Elisa Pierpaoli, Fiorenza Orlando, Sara Pierpaoli, Arianna Smorlesi

Journal:

Cancer Immunology, Immunotherapy

Year:

2012

Language:

english

File:

PDF, 388 KB

english, 2012

7

Integrin alphavbeta6 promotes tumor tolerance in colorectal cancer

Shao-Bo Yang, Yun Du, Ben-Yan Wu, Shi-Ping Xu, Jun-Bao Wen, Min Zhu, Chang-Hao Cai, Ping-Chang Yang

Journal:

Cancer Immunology, Immunotherapy

Year:

2012

Language:

english

File:

PDF, 396 KB

english, 2012

8

Design of immunogenic and effective multi-epitope DNA vaccines for melanoma

Hyun-Il Cho, Esteban Celis

Journal:

Cancer Immunology, Immunotherapy

Year:

2012

Language:

english

File:

PDF, 547 KB

english, 2012

9

Activated human γδ T cells induce peptide-specific CD8+ T-cell responses to tumor-associated self-antigens

Bianca Altvater, Sibylle Pscherer, Silke Landmeier, Sareetha Kailayangiri, Barbara Savoldo, Heribert Juergens, Claudia Rossig

Journal:

Cancer Immunology, Immunotherapy

Year:

2012

Language:

english

File:

PDF, 570 KB

english, 2012

10

Inclusive estimation of complex antigen presentation functions of monocyte-derived dendritic cells differentiated under normoxia and hypoxia conditions

Toshitatsu Ogino, Hideya Onishi, Hiroyuki Suzuki, Takashi Morisaki, Masao Tanaka, Mitsuo Katano

Journal:

Cancer Immunology, Immunotherapy

Year:

2012

Language:

english

File:

PDF, 1.21 MB

english, 2012

11

Ontak reduces the immunosuppressive tumor environment and enhances successful therapeutic vaccination in HER-2/neu-tolerant mice

Angelos D. Gritzapis, Ioannis F. Voutsas, Constantin N. Baxevanis

Journal:

Cancer Immunology, Immunotherapy

Year:

2012

Language:

english

File:

PDF, 701 KB

english, 2012

12

A rebuttal to the potential anti-tumour benefit ofHelicobacter pylori-induced neutrophil-activating protein

Jannis Kountouras, Christos Zavos, Emmanuel Gavalas, Georgia Deretzi, Afroditi Tsona, Panagiotis Katsinelos, Savas Grigoriadis, Ioannis Pilpilidis, Dimitrios Tzilves, Elizabeth Vardaka, Konstantinos M

Journal:

Cancer Immunology, Immunotherapy

Year:

2012

Language:

english

File:

PDF, 196 KB

english, 2012

13

Response to the rebuttal letter of Kountouras and colleagues regarding the paper by Codolo et al. ‘HP-NAP inhibits the growth of bladder cancer in mice by activating a cytotoxic Th1 response’

Andrew M. Jackson, Hester A. Franks

Journal:

Cancer Immunology, Immunotherapy

Year:

2012

Language:

english

File:

PDF, 159 KB

english, 2012

14

HP-NAP new therapy for bladder cancer: numquam periculum sine periculo vincitur

Gaia Codolo, Matteo Fassan, Mario M. D’Elios, Marina de Bernard

Journal:

Cancer Immunology, Immunotherapy

Year:

2012

Language:

english

File:

PDF, 152 KB

english, 2012

15

Gene silencing of TGF-β1 enhances antitumor immunity induced with a dendritic cell vaccine by reducing tumor-associated regulatory T cells

Helen Conroy, Karen C. Galvin, Sarah C. Higgins, Kingston H. G. Mills

Journal:

Cancer Immunology, Immunotherapy

Year:

2012

Language:

english

File:

PDF, 391 KB

english, 2012

16

Advances in cellular therapy: 6th international symposium on the clinical use of cellular products, March 24 and 25, 2011, Erlangen, Germany

Evelyn Ullrich, Jacobus Bosch, Michael Aigner, Simon Voelkl, Irena Kroeger, Petra Hoffmann, Marina Kreutz, Diana Dudziak, Armin Gerbitz

Journal:

Cancer Immunology, Immunotherapy

Year:

2012

Language:

english

File:

PDF, 211 KB

english, 2012

To build up a library is to create a life. It’s never just a random collection of books.

— Carlos María Domínguez

Official channel

Z-Library Desktop Launcher

Tor version

Z-Library

Z-Library Since 2009 support@z-lib.do

EnglishРусскийEspañolItalianoελληνικάاللغة العربيةBahasa IndonesiaBahasa Malaysiaहिन्दीDeutschFrançaisPortuguêsУкраїнськаPolski中文繁體中文日本語Tiếng ViệtAzərbaycan DiliՀայոց լեզուภาษาไทยTürk Diliქართველიবাংলাپښتوతెలుగుاردو한국어SrpskiБългарски